A Magnetic Resonance Imaging Analysis of Shrinkage of Transplanted Fresh-Frozen Lateral Meniscal Allografts During a Minimum Follow-up of 8 Years.
To evaluate the incidence and degree of shrinkage of transplanted fresh-frozen meniscal allografts in a long-term period of >8 years and to investigate whether the shrinkage of allograft progresses and is associated with inferior clinical and radiologic outcomes after meniscal allograft transplantation (MAT) in the long term. Twenty-two knees were reviewed in 20 patients (mean age, 31.41 ± 9.11 years) who underwent isolated lateral MAT. All patients were followed with magnetic resonance imaging (MRI) for at least 8 years (mean, 11.78 ± 3.10 years). The allograft widths of the anterior horn, mid-body, and posterior horn at 1 and >8 years postoperatively were measured by using MRI. To estimate the degree of shrinkage, the relative changes in widths during intervals were calculated. Patients were categorized into 4 groups according to shrinkage degree: minimal (<10%), mild (10%-25%), moderate (25%-50%), and severe (>50%). The joint space width was measured on the weightbearing radiographs to evaluate the radiologic outcome. The Lysholm score was used to evaluate the clinical outcome. The relative change in the width of the anterior horn, mid-body, and posterior horn, compared with that 1 year postoperatively, was 82.7% (95% confidence interval 77.4%-87.5%), 75.9% (70.7%-81.0%), and 85.0% (81.4%-88.5%), respectively. The shrinkage degree was greater at the mid-body than at the anterior and posterior horns. About 70% of allografts showed ≥10% shrinkage of the posterior horn. Meniscal shrinkage did not show significant correlation with clinical and radiologic outcome. At long-term follow-up (>8 years), shrinkage of transplanted fresh-frozen meniscal allografts progressed at 1 year postoperative. On average, the shrinkage was mild and more prominent in the mid-body than in the anterior or posterior horn. In this study, it could not be concluded that the shrinkage of allografts was significantly associated with inferior clinical and radiologic outcomes in the long term. Level IV, therapeutic case series.